TNFRSF10B and glioblastoma: The underlying mechanisms may also involve the activation of extrinsic apoptosis, as morusin treatment promotes expression of an extrinsic receptor, Death receptor 5, thereby sensitizing the glioblastoma to TRAIL, an antitumor chemical that mimics ligands for the extrinsic receptor [38].